Kiribati has one of the highest rates of leprosy in the world and with sea level rise threatening its existence there is likely to be mass migration of i-Kiribati people to neighbouring countries such as Aotearoa New Zealand.
This project will use a next generation deep sequencing technique to identify drug resistant leprosy and the potential impact of mass treatment of household contacts of those newly-diagnosed with the disease in Kiribati. The project will also explore the degree of susceptibility to severe adverse reactions to common treatments for leprosy.